外周免疫与肌萎缩侧索硬化快速进展的相关性
这项纵向队列研究纳入35名健康对照和119例ALS患者,纵向追踪外周免疫细胞变化,发现ALS患者白细胞、中性粒细胞、单核细胞及NK细胞计数升高,且早期免疫细胞数量变化与ALSFRS-R评分下降显著相关,提示免疫系统变化可能参与ALS病理过程。
要点
- ALS患者外周血总白细胞、中性粒细胞、CD16+和CD16-单核细胞及NK细胞计数均高于健康对照。
- 早期中性粒细胞和CD4 T细胞数量变化与ALSFRS-R评分下降显著相关。
- ALS病程中可见CD11b+髓系细胞表达HLA-DR、CD11c和CX3CR1的一过性急性增加。
核心结论
- ALS患者存在外周免疫细胞计数升高,且早期免疫细胞数量变化与疾病进展相关,免疫系统变化可能参与ALS病理特征。
研究设计与样本
- 纵向队列研究,纳入35名健康对照和119例ALS患者,于2014年6月18日至2016年5月26日在密歇根大学ALS诊所采集外周血,每6至12个月随访,51例ALS患者提供多次样本。
主要发现
- 与对照相比,ALS患者总白细胞计数均值(SEM)为5.53(0.16;95%CI 5.21-5.84)×10^6/mL vs 4.57(0.29;95%CI 3.94-5.11)×10^6/mL。
- ALS患者中性粒细胞计数为3.80(0.12;95%CI 3.56-4.04)×10^6/mL vs 2.87(0.23;95%CI 2.40-3.35)×10^6/mL。
- ALS患者CD16+单核细胞计数为0.04(0.002;95%CI 0.03-0.04)×10^6/mL vs 0.03(0.003;95%CI 0.02-0.04)×10^6/mL。
- ALS患者CD16-单核细胞计数为0.29(0.01;95%CI 0.27-0.31)×10^6/mL vs 0.25(0.02;95%CI 0.21-0.30)×10^6/mL。
- ALS患者自然杀伤细胞计数为0.18(0.01;95%CI 0.16-0.21)×10^6/mL vs 0.13(0.02;95%CI 0.10-0.17)×10^6/mL。
关键数值与推荐
- 中性粒细胞每变化11.47×10^4/mL(SD 58.04×10^4/mL)每年,ALSFRS-R评分变化为-4.37(95%CI -6.60至-2.14)。
- CD4 T细胞每变化-3.72×10^4/mL(SD 26.21×10^4/mL)每年,ALSFRS-R评分变化为-30.47(95%CI -46.02至-14.94)。
临床怎么用
- 监测外周血中性粒细胞和CD4 T细胞等免疫细胞数量的早期变化,可能有助于评估ALS疾病进展速度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Amyotrophic lateral sclerosis (ALS) has an immune component, but previous human studies have not examined immune changes over time. OBJECTIVES: To assess peripheral inflammatory markers in participants with ALS and healthy control individuals and to track immune changes in ALS and determine whether these changes correlate with disease progression. DESIGN, SETTING, AND PARTICIPANTS: In this longitudinal cohort study, leukocytes were isolated from peripheral blood samples from 35 controls and 119 participants with ALS at the ALS Clinic of the University of Michigan, Ann Arbor, from June 18, 2014, through May 26, 2016. Follow-up visits occurred every 6 to 12 months. Fifty-one participants with ALS provided samples at multiple points. Immune cell populations were measured and compared between control and ALS groups. Surface marker expression of CD11b+ myeloid cells was also assessed. Changes over time were correlated with disease progression using multivariate regression. MAIN OUTCOMES AND MEASURES: The number of immune cells per milliliter of blood and the fold expression of cell surface markers. Multivariate regression models were used to correlate changes in immune metrics with changes on the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R). RESULTS: Thirty-five controls (17 women [48.6%] and 18 men [51.4%]; mean [SD] age, 63.5 [9.9] years) and 119 participants with ALS (50 women [42.0%] and 69 men [68.0%]; mean [SD] age, 61.4 [11.5] years) were enrolled. Compared with controls, participants with ALS had increased mean (SEM) counts ( × 106/mL) of total leukocytes (4.57 [0.29; 95% CI, 3.94-5.11] vs 5.53 [0.16; 95% CI, 5.21-5.84]), neutrophils (2.87 [0.23; 95% CI, 2.40-3.35] vs 3.80 [0.12; 95% CI, 3.56-4.04]), CD16+ monocytes (0.03 [0.003; 95% CI, 0.02-0.04] vs 0.04 [0.002; 95% CI, 0.03-0.04]), CD16- monocytes (0.25 [0.02; 95% CI, 0.21-0.30] vs 0.29 [0.01; 95% CI, 0.27-0.31]), and natural killer cells (0.13 [0.02; 95% CI, 0.10-0.17] vs 0.18 [0.01; 95% CI, 0.16-0.21]). We also observed an acute, transient increase in a population of CD11b+ myeloid cells expressing HLA-DR, CD11c, and CX3CR1. Finally, early changes in immune cell numbers had a significant correlation with disease progression measured by change in ALSFRS-R score, particularly neutrophils (-4.37 [95% CI, -6.60 to -2.14] per 11.47 × 104/mL [SD, 58.04 × 104/mL] per year) and CD4 T cells (-30.47 [95% CI, -46.02 to -14.94] per -3.72 × 104/mL [SD, 26.21 × 104/mL] per year). CONCLUSIONS AND RELEVANCE: Changes in the immune system occur during ALS and may contribute to the pathologic features of ALS.
引用
- Murdock BJ, Zhou T, Kashlan SR, et al. Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression. JAMA Neurol. 2017. PMID: 28973548. doi:10.1001/jamaneurol.2017.2255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。